How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists

Abstract Clinicians, researchers, and the public frequently turn to digital channels and social media for up-to-the-minute information on novel therapeutics and vaccines. The value of credible infectious diseases drug information is more apparent in the setting of the coronavirus disease 2019 (COVID...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2022-05, Vol.74 (Supplement_3), p.e23-e33
Main Authors: Cole, Kelli A, Zhou, Anna Y, Jones, Travis, Moore, W Justin, Chandler, Elisabeth L, Zafonte, Veronica B, Morrisette, Taylor, Gauthier, Timothy P, Kisgen, Jamie, Barner, Amanda, Johnson, Melissa D, Tagare, R Dawn, Justo, Julie Ann
Format: Article
Language:English
Subjects:
Communicable Diseases - drug therapy
Communicable Diseases - epidemiology
COVID-19
Humans
Online Only
Pandemics
Pharmacists
Social Media
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Clinicians, researchers, and the public frequently turn to digital channels and social media for up-to-the-minute information on novel therapeutics and vaccines. The value of credible infectious diseases drug information is more apparent in the setting of the coronavirus disease 2019 (COVID-19) pandemic. This viewpoint by the Society of Infectious Diseases Pharmacists (SIDP) provides guidance on utilizing social media platforms to optimize infectious diseases pharmacotherapy. It includes tips for all levels of users but primarily serves a guide for the infectious diseases clinician who has not yet joined social media. It compares various social media platforms and suggests which to begin with based on user needs, recommends efficient curation of social media content, and outlines a stepwise approach (shown below) to increasing engagement over time. This summary will hopefully spur further quality content and engagement regarding drug information from the infectious diseases social media network. Graphical Abstract Graphical Abstract
ISSN:1058-4838
1537-6591
1537-6591
DOI:10.1093/cid/ciac081